Skip to main navigation Skip to search Skip to main content

Up-regulation of P-glycoprotein confers acquired resistance to 6-mercaptopurine in human chronic myeloid leukemia cells

  • Xing Xiang Peng
  • , Zhi Shi
  • , Amit K. Tiwari
  • , Vijaya L. Damaraju
  • , Liwu Fu
  • , Carol E. Cass
  • , Charles R. Ashby
  • , Gary D. Kruh
  • , Zhe Sheng Chen
  • St. John's University
  • New York University
  • Sun Yat-Sen University
  • University of Alberta
  • University of Illinois at Chicago

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

To investigate the mechanisms of cellular resistance to 6-mercaptopurine (6-MP) in chronic myeloid leukemia (CML), a 6-MP resistant cell line (K562-MP5) was established by stepwise selection of the CML cell line (K562). The results of the drug sensitivity analysis of the K562-MP5 cell line revealed the cells to be 339-fold more resistant to 6-MP compared with the parental K562 cells. K562-MP5 cells exhibited decreased accumulation and increased efflux of [14C]6-MP and its metabolites. In addition, K562-MP5 cells showed increased [3H]MTX transport. K562-MP5 cells over--expressed P-glycoprotein (P-gp) and up-regulated MDR1 mRNA levels. Taken together, these results suggest that the up-regulation of P-gp, which contributes to the decreased accumulation by increasing the efflux of 6-MP and its metabolites, underlies the mechanism of 6-MP resistance in K562 cells.

Original languageEnglish
Pages (from-to)549-556
Number of pages8
JournalOncology Letters
Volume2
Issue number3
DOIs
StatePublished - May 2011
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • 6-mercaptopurine
  • ATP binding cassette transporter
  • Chronic myeloid leukemia
  • Multidrug resistance
  • P-glycoprotein

Fingerprint

Dive into the research topics of 'Up-regulation of P-glycoprotein confers acquired resistance to 6-mercaptopurine in human chronic myeloid leukemia cells'. Together they form a unique fingerprint.

Cite this